1. Home
  2. JAGX vs LRHC Comparison

JAGX vs LRHC Comparison

Compare JAGX & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.98

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo La Rosa Holdings Corp.

LRHC

La Rosa Holdings Corp.

HOLD

Current Price

$0.97

Market Cap

1.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
LRHC
Founded
2013
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
1.8M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
JAGX
LRHC
Price
$0.98
$0.97
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
66.1K
89.3K
Earning Date
04-07-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
$68,507,806.00
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.25
52 Week High
$8.00
$9.72

Technical Indicators

Market Signals
Indicator
JAGX
LRHC
Relative Strength Index (RSI) 22.36 42.85
Support Level $0.60 $0.58
Resistance Level $0.99 $1.23
Average True Range (ATR) 0.24 0.10
MACD -0.13 -0.01
Stochastic Oscillator 0.00 30.30

Price Performance

Historical Comparison
JAGX
LRHC

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. The company derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

Share on Social Networks: